These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

168 related articles for article (PubMed ID: 3379071)

  • 21. Pharmacological distinction between dantrolene and ryanodine binding sites: evidence from normal and malignant hyperthermia-susceptible porcine skeletal muscle.
    Palnitkar SS; Mickelson JR; Louis CF; Parness J
    Biochem J; 1997 Sep; 326 ( Pt 3)(Pt 3):847-52. PubMed ID: 9307036
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Post mortem changes in Ca2+ transporting proteins of sarcoplasmic reticulum in dependence on malignant hyperthermia status in pigs.
    Küchenmeister U; Kuhn G; Wegner J; Nürnberg G; Ender K
    Mol Cell Biochem; 1999 May; 195(1-2):37-46. PubMed ID: 10395067
    [TBL] [Abstract][Full Text] [Related]  

  • 23. [3H]ryanodine as a probe of changes in the functional state of the Ca(2+)-release channel in malignant hyperthermia.
    Hawkes MJ; Nelson TE; Hamilton SL
    J Biol Chem; 1992 Apr; 267(10):6702-9. PubMed ID: 1313019
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Characterization of multiple [3H]ryanodine binding sites on the Ca2+ release channel of sarcoplasmic reticulum from skeletal and cardiac muscle: evidence for a sequential mechanism in ryanodine action.
    Pessah IN; Zimanyi I
    Mol Pharmacol; 1991 May; 39(5):679-89. PubMed ID: 1851961
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Anthraquinone-sensitized Ca2+ release channel from rat cardiac sarcoplasmic reticulum: possible receptor-mediated mechanism of doxorubicin cardiomyopathy.
    Pessah IN; Durie EL; Schiedt MJ; Zimanyi I
    Mol Pharmacol; 1990 Apr; 37(4):503-14. PubMed ID: 2157959
    [TBL] [Abstract][Full Text] [Related]  

  • 26. The effect of calcium channel antagonists and BAY K 8644 on calcium fluxes of malignant hyperpyrexia-susceptible muscle.
    Foster PS; Denborough MA
    Int J Biochem; 1993 Apr; 25(4):495-504. PubMed ID: 7682190
    [TBL] [Abstract][Full Text] [Related]  

  • 27. 4-Chloro-m-cresol: a specific tool to distinguish between malignant hyperthermia-susceptible and normal muscle.
    Herrmann-Frank A; Richter M; Lehmann-Horn F
    Biochem Pharmacol; 1996 Jul; 52(1):149-55. PubMed ID: 8678899
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Altered transverse tubule dihydropyridine receptor binding in malignant hyperthermia.
    Ervasti JM; Claessens MT; Mickelson JR; Louis CF
    J Biol Chem; 1989 Feb; 264(5):2711-7. PubMed ID: 2536721
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Comparison of [3H]ryanodine receptors and Ca++ release from rat cardiac and rabbit skeletal muscle sarcoplasmic reticulum.
    Zimányi I; Pessah IN
    J Pharmacol Exp Ther; 1991 Mar; 256(3):938-46. PubMed ID: 1848635
    [TBL] [Abstract][Full Text] [Related]  

  • 30. The calcium-ryanodine receptor complex of skeletal and cardiac muscle.
    Pessah IN; Waterhouse AL; Casida JE
    Biochem Biophys Res Commun; 1985 Apr; 128(1):449-56. PubMed ID: 3985981
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Effects of propofol on Ca2+ regulation by malignant hyperthermia-susceptible muscle membranes.
    Fruen BR; Mickelson JR; Roghair TJ; Litterer LA; Louis CF
    Anesthesiology; 1995 May; 82(5):1274-82. PubMed ID: 7741303
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Ca2+-activated ryanodine binding: mechanisms of sensitivity and intensity modulation by Mg2+, caffeine, and adenine nucleotides.
    Pessah IN; Stambuk RA; Casida JE
    Mol Pharmacol; 1987 Mar; 31(3):232-8. PubMed ID: 2436032
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Structural and functional characterization of the purified cardiac ryanodine receptor-Ca2+ release channel complex.
    Anderson K; Lai FA; Liu QY; Rousseau E; Erickson HP; Meissner G
    J Biol Chem; 1989 Jan; 264(2):1329-35. PubMed ID: 2463249
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Positive cooperativity of ryanodine binding to the calcium release channel of sarcoplasmic reticulum from heart and skeletal muscle.
    McGrew SG; Wolleben C; Siegl P; Inui M; Fleischer S
    Biochemistry; 1989 Feb; 28(4):1686-91. PubMed ID: 2541762
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Skeletal muscle excitation-contraction coupling. I. Transverse tubule control of peeled fiber Ca2+-induced Ca2+ release in normal and malignant hyperthermic muscles.
    Donaldson SK; Gallant EM; Huetteman DA
    Pflugers Arch; 1989 May; 414(1):15-23. PubMed ID: 2726433
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Isolation of the ryanodine receptor from cardiac sarcoplasmic reticulum and identity with the feet structures.
    Inui M; Saito A; Fleischer S
    J Biol Chem; 1987 Nov; 262(32):15637-42. PubMed ID: 3680217
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Evidence for intraluminal Ca++ regulatory site defect in sarcoplasmic reticulum from malignant hyperthermia pig muscle.
    Nelson TE; Lin M; Volpe P
    J Pharmacol Exp Ther; 1991 Feb; 256(2):645-9. PubMed ID: 1847206
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Characterization of junctional and longitudinal sarcoplasmic reticulum from heart muscle.
    Inui M; Wang S; Saito A; Fleischer S
    J Biol Chem; 1988 Aug; 263(22):10843-50. PubMed ID: 2968985
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Identification of dantrolene binding sites in porcine skeletal muscle sarcoplasmic reticulum.
    Parness J; Palnitkar SS
    J Biol Chem; 1995 Aug; 270(31):18465-72. PubMed ID: 7629173
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Mg2+ dependence of halothane-induced Ca2+ release from the sarcoplasmic reticulum in skeletal muscle from humans susceptible to malignant hyperthermia.
    Duke AM; Hopkins PM; Halsal JP; Steele DS
    Anesthesiology; 2004 Dec; 101(6):1339-46. PubMed ID: 15564941
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.